Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 3, 2009, Pages 219-223

  Lin, Jie ^a,b   Zhang, Muxun ^a   Song, Fangfang ^a   Qin, Jin ^a   Wang, Rui ^a   Yao, Ping ^a   Ying, Chenjiang ^a   Hu, Frank B ^c   Liu, Liegang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

C reactive protein; Impaired fasting glucose; Impaired glucose tolerance; Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; ASIAN; BLOOD; CHINA; CROSS-SECTIONAL STUDY; ETHNIC GROUP; GLUCOSE INTOLERANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; PREDIABETIC STATE;

EID: 65649145150     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.923     Document Type: Article

References (24)

1. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001; 50: 2384-2389.
2. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
3. Dehghan A, Kardys I, de Maat MP, et al. Genetic variation, Creactive protein levels, and incidence of diabetes. Diabetes 2007; 56: 872-878.
4. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53: 693-700.
5. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002; 25: 2016-2021.
6. Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 2003; 26: 2754-2757.
7. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
8. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
9. Abdul-Ghani MA, Sabbah M, Kher J, Minuchin O, Vardi P, Raz I. Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT. Diabetes Metab Res Rev 2006; 22: 126-130.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007; 30: S42-S47.
11. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708-723.
12. Baron AD. Impaired glucose tolerance as a disease. Am J Cardiol 2001; 88: 16H-19H.
13. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
14. Englund Ogge L, Brohall G, Behre CJ, Schmidt C, Fagerberg B. Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-Year-Old caucasian women: A population-based study with a focus on impaired glucose regulation. Diabetes Care 2006; 29: 908-913.
15. Song F, Jia W, Yao Y, et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci (Lond) 2007; 112: 599-606.
16. Meisinger C, Löwel H, Thorand B, Döring A. Leisure time physical activity and the risk of type 2 diabetes in men and women from the general population. The MONICA/KORA Augsburg Cohort Study. Diabetologia 2005; 48: 27-34.
17. Moran A, Harbour DV, Teeter LD, Musser JM, Graviss EA. Is alcohol use associated with cavitary disease in tuberculosis? Alcohol Clin Exp Res 2007; 31: 33-38.
18. Ford E. Body mass index, diabetes, and C-reactive protein among US adults. Diabetes Care 1999; 22: 1971-1977.
19. Mendall MA, Patel P, Ballam L, Strachan D, North field TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-1065.
20. Nakanishi N, Shiraishi T, Wada M. Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study. Intern Med 2005; 44: 542-547.
21. Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study. Diabet Med 2008; 25: 747-750.
22. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241-1248.
23. van de Ree MA, Huisman MV, Princen HM, Meinders AE, Kluft C, DALI-Study Group. Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 2003; 166: 129-135.
24. Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr. Angiotensinconverting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 2005; 46: 821-826.